Kusne, Y., Mosalem, O. M., Quillen, J., Buckner-Petty, S., Muniz, M., Sartor, O., Johnson, G. B., Childs, D. S. and Patnaik, M. M. (2025) “Hematologic dysfunction and myeloid neoplasm risk in patients treated with lutetium<sup>-177</sup&gt; prostate-specific antigen membrane therapy”, Haematologica. Pavia, Italy, 110(9), pp. 2187-2192. doi: 10.3324/haematol.2024.286808.